Symptoms (%) | Seronegative (CHIK-), % | Seropositive (CHIK+), % | Crude prevalence ratio | 95% CI | Pvalue |
---|---|---|---|---|---|
Musculoskeletal pain | 17.1 | 42.8 | 2.5 | 1.9 to 3.1 | <0.001 |
Fatigue | 46.4 | 53.6 | 1.1 | 1.0 to 1.3 | 0.04 |
Light cerebral disorders | 57.0 | 75.3 | 1.3 | 1.1 to 1.5 | <0.001 |
Headache | 20.0 | 25.9 | 1.3 | 1.0 to 1.7 | 0.05 |
Sleep disorders | 24.1 | 31.2 | 1.3 | 1.0 to 1.7 | 0.02 |
Memory troubles | 25.4 | 42.2 | 1.7 | 1.3 to 2.0 | <0.001 |
Attention difficulties | 19.9 | 37.1 | 1.9 | 1.4 to 2.3 | <0.001 |
Mood disturbance | 23.7 | 38.4 | 1.6 | 1.3 to 2.0 | <0.001 |
Depression | 8.0 | 14.7 | 1.8 | 1.2 to 2.7 | 0.002 |
Sensorineural disorders | 37.2 | 48.8 | 1.4 | 1.1 to 1.5 | 0.001 |
Blurred vision | 30.2 | 42.0 | 1.4 | 1.1 to 1.7 | <0.001 |
Hearing difficulties | 13.0 | 17.8 | 1.4 | 0.9 to 1.9 | 0.05 |
Digestive disorders | 15.0 | 18.3 | 1.2 | 0.8 to 1.7 | 0.21 |
Dermatological disorders | 34.2 | 36.1 | 1.2 | 0.8 to 1.7 | 0.205 |
Skin lesions | 17.2 | 19.9 | 1.2 | 0.8 to 1.5 | 0.33 |
Alopecia | 21.4 | 21.9 | 1.0 | 0.7 to 1.3 | 0.835 |